PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
Click on the title to browse this issue
This crossover randomized clinical trial aims to determine the effect of different arm positions on blood pressure readings.
Study identifies easy exercises to help pediatric providers assess functioning in children with pain and evaluate progress after intervention.Â
Farmer Robert Strathern says potato growing is becoming a riskier business.
This week we’re joined by the brains behind South Australia’s EdChat chatbot. It was the first state in Australia to start pilot a custom built…
Former agency insiders are helping vaping companies and tobacco firms press their case.
Dive into the heart of finance and technology with this insightful conversation! Explore the latest in FinTech trends, from the rise of AI to the…
The lawsuit argues that the Medicare program was “arbitrary and capricious” in how it calculated the metrics for Humana’s health plans.Â
An innovative study, published in Nature Communications, reveals the mechanism behind two seemingly contradictory effects of fear memories: the inability to forget yet the difficulty…
The National Institute for Health and Care Excellence (NICE) has proposed more comprehensive falls assessments and management of older people at risk of falls, including…